亚太地区非处方药和膳食补充剂市场预测至 2027 年 - COVID-19 影响和按产品划分的区域分析（咳嗽和感冒产品、维生素和膳食补充剂、镇痛药、胃肠道产品、助眠剂、口腔护理产品、眼科产品、抗酸剂、女性用药）护理及其他）；类型（品牌、通用）；剂型（片剂、胶囊、粉剂、软膏、液体等）；分销渠道（医院和零售药店、零售店、在线渠道等）；和国家
No. of Pages: 198 | Report Code: TIPRE00016069 | Category: Life Sciences
No. of Pages: 198 | Report Code: TIPRE00016069 | Category: Life Sciences
市场介绍
非处方药 (OTC) 可供公众购买一般使用。这些药物不需要医生处方。非处方药可用于治疗因疾病引起的各种医学症状，例如咳嗽和感冒、腹泻、胃灼热、便秘、痤疮、疼痛等。另一方面，出于健身目的，膳食补充剂可以在柜台购买。然而，在某些情况下，当一个人病危或需要治疗时，购买含有药物成分的膳食补充剂需要医生的处方。这些非处方药和营养补充剂有两种类型，例如品牌药或仿制药。
市场概况和动态
亚太地区 OTC 药物和膳食补充剂市场预计将从 2019 年的 551.572 亿美元增至 2027 年的 961.568 亿美元。预计从 2020 年开始，该市场将以 7.3% 的复合年增长率增长到2027年。推动市场增长的因素包括人们对一般健康问题的认识不断提高，而非处方药的优势预计将推动市场的增长。然而，政府对非处方药的严格监管是阻碍市场增长的主要因素。新冠肺炎疫情影响了亚太地区国家，导致大量冠状病毒病例。人们正在购买市场上更多的免疫力增强产品来对抗冠状病毒的影响
关键细分市场
从产品来看，2019年镇痛药市场份额最大；然而，预计维生素和膳食补充剂细分市场在预测期内将实现市场上最高的复合年增长率。就类型而言，仿制药细分市场在 2019 年占据了更大的市场份额，预计类似细分市场在预测期内将占据更高的市场份额。同样，就形式而言，平板电脑细分市场在 2019 年占据了更大的市场份额，预计在预测期内市场复合年增长率将更高。就分销渠道而言，医院和零售药店在 2019 年占据最大市场份额：然而，预计在线渠道领域在预测期内的复合年增长率最高。
< span>
世界卫生组织 (WHO)、世界心脏联合会、国家心脏中心生物技术信息治疗产品管理局是报告中包含的亚太 OTC 药物和膳食补充剂市场的一些主要主要和次要来源。
原因购买报告
亚太非处方药和膳食补充剂市场细分
< strong>公司简介
Strategic insights for Asia Pacific OTC Drug and Dietary Supplement involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 55,157.2 Million |
| Market Size by 2027 | US$ 96,156.8 Million |
| Global CAGR (2020 - 2027) | 7.3% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By 产品
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific OTC Drug and Dietary Supplement refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific OTC Drug and Dietary Supplement Market is valued at US$ 55,157.2 Million in 2019, it is projected to reach US$ 96,156.8 Million by 2027.
As per our report Asia Pacific OTC Drug and Dietary Supplement Market, the market size is valued at US$ 55,157.2 Million in 2019, projecting it to reach US$ 96,156.8 Million by 2027. This translates to a CAGR of approximately 7.3% during the forecast period.
The Asia Pacific OTC Drug and Dietary Supplement Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific OTC Drug and Dietary Supplement Market report:
The Asia Pacific OTC Drug and Dietary Supplement Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific OTC Drug and Dietary Supplement Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific OTC Drug and Dietary Supplement Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific OTC Drug and Dietary Supplement Market
